-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ATB-1651 in Onychomycosis (Tinea Unguium)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ATB-1651 in Onychomycosis (Tinea Unguium) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ATB-1651 in Onychomycosis (Tinea Unguium) Drug Details: ATB-1651 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ATB-1651 in Onychomycosis (Tinea Unguium)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ATB-1651 in Onychomycosis (Tinea Unguium) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ATB-1651 in Onychomycosis (Tinea Unguium) Drug Details: ATB-1651 is under...
-
Product Insights
ATB/ Kawasan Ind – Kaveling K-I Water Treatment Plant Phase II – North Sumatra
The ATB/ Kawasan Ind – Kaveling K-I Water Treatment Plant Phase II – North Sumatra project involves the construction of a wastewater treatment plant in North Sumatra, Indonesia. Equip yourself with the essential tools needed to make informed and profitable decisions with our ATB/ Kawasan Ind – Kaveling K-I Water Treatment Plant Phase II – North Sumatra report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Quemliclustat in Non-Small Cell Lung Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Quemliclustat in Non-Small Cell Lung Cancer Drug Details: Quemliclustat is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ursodiol in Biliary Tract Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ursodiol in Biliary Tract Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ursodiol in Biliary Tract Disease Drug Details: Ursodiol (DWJ-1439) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tusamitamab Ravtansine in Bladder Carcinoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Tusamitamab Ravtansine in Bladder Carcinoma Drug Details: Tusamitamab ravtansine is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Otenaproxesul in Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Otenaproxesul in Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Otenaproxesul in Pain Drug Details: ATB-346 (otenaproxesul) is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Otenaproxesul in Osteoarthritis Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Otenaproxesul in Osteoarthritis Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Otenaproxesul in Osteoarthritis Pain Drug Details: ATB-346 (otenaproxesul) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bedaquiline Fumarate in Leprosy
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Bedaquiline Fumarate in Leprosy Drug Details: Bedaquiline Fumarate (Sirturo) is a diarylquinoline antimycobacterial drug. It...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RZ-402 in Diabetic Macular Edema
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RZ-402 in Diabetic Macular Edema report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.RZ-402 in Diabetic Macular Edema Drug Details:RZ-402 is under development for the treatment...